CUV 3.92% $15.65 clinuvel pharmaceuticals limited

The shorters went in hard in the months prior to the FDA...

  1. 929 Posts.
    lightbulb Created with Sketch. 573
    The shorters went in hard in the months prior to the FDA approval decision in 2019 and rather than something that should have destroyed them, they've been thriving ever since. Current management are the best friends of the shorters and they won't be leaving any time soon because they've made a packet from this company and it is all down to the pace of progress, broken and buried timeline promises and litany of utterly bizarre management decisions - what other company pays hundreds of thousands of dollars to a conductor who has no connection to any of the conditions they are pursuing and a tiny social media following to be an 'ambassader'. That sums them up.
    Last edited by Fernit: Thursday, 14:55
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.65
Change
0.590(3.92%)
Mkt cap ! $783.7M
Open High Low Value Volume
$15.27 $15.65 $15.05 $967.0K 62.66K

Buyers (Bids)

No. Vol. Price($)
1 227 $15.48
 

Sellers (Offers)

Price($) Vol. No.
$15.65 999 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.